Fawzi Kerkouri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fawzi Kerkouri has a total of 423 co-authors. Here are the top co-authors by number of shared publications:
Jacques Mansourati
Department of Cardiology, University Hospital of Brest
5 shared publications- Eloi Marijon
Division of Cardiology, European Georges Pompidou Hospital, Paris, France
4 shared publications - Rodrigue Garcia
Cardiology Department & Centre d'Investigation Clinique 1402, University Hospital Centre Poitiers, Poitiers, France
4 shared publications Vincent Mansourati
Department of Cardiology, University Hospital of Brest
4 shared publicationsPascal Defaye
University Hospital of Grenoble, Grenoble, France
3 shared publicationsPierre Khattar
Department of Cardiology Hospital of Lorient Lorient France
3 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 2001066
Cutaneous warning signs of cardiac implantable electronic device infection: a pictorial guide for clinicians
Cardiac implantable electronic device (CIED) infections are potentially life-threatening complications of pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices. Although fever, bacteremia, and infective endocarditis may occur, the earliest—and sometimes only—manifestations are cutaneous abnormalities overlying the generator pocket. These findings may be subtle and mistaken for postoperative changes, hematoma, contact dermatitis, mechanical irritation, or impaired wound healing. Because patients may initially present to general practitioners, internists, emergency physicians, or dermatologists, early recognition is essential. This pictorial review illustrates the spectrum of cutaneous manifestations of CIED infection, ranging from localized erythema, swelling, pain, and delayed wound healing to erosion, sinus tract formation, purulent drainage, necrosis, and hardware exposure. It also highlights practical warning signs, appropriate referral pathways, and interventions that should be avoided before specialist assessment. Infection may extend from the pocket along the intravascular leads to the bloodstream and cardiac structures, leading to bacteremia, endocarditis, sepsis, and death. Any persistent or progressive abnormality over a CIED pocket warrants prompt evaluation, whereas purulent drainage, sinus formation, or hardware exposure should be considered evidence of device infection and require urgent electrophysiology assessment, even in the absence of systemic symptoms.
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 2001066
Open AccessCutaneous warning signs of cardiac implantable electronic device infection: a pictorial guide for clinicians
Cardiac implantable electronic device (CIED) infections are potentially life-threatening complications of pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices. Although fever, bacteremia, and infective endocarditis may occur, the earliest—and sometimes only—manifestations are cutaneous abnormalities overlying the generator pocket. These findings may be subtle and mistaken for postoperative changes, hematoma, contact dermatitis, mechanical irritation, or impaired wound healing. Because patients may initially present to general practitioners, internists, emergency physicians, or dermatologists, early recognition is essential. This pictorial review illustrates the spectrum of cutaneous manifestations of CIED infection, ranging from localized erythema, swelling, pain, and delayed wound healing to erosion, sinus tract formation, purulent drainage, necrosis, and hardware exposure. It also highlights practical warning signs, appropriate referral pathways, and interventions that should be avoided before specialist assessment. Infection may extend from the pocket along the intravascular leads to the bloodstream and cardiac structures, leading to bacteremia, endocarditis, sepsis, and death. Any persistent or progressive abnormality over a CIED pocket warrants prompt evaluation, whereas purulent drainage, sinus formation, or hardware exposure should be considered evidence of device infection and require urgent electrophysiology assessment, even in the absence of systemic symptoms.
- Open Access
- 12 June 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (7)
Early complications and long-term outcome of patients treated with a Subcutaneous Cardioverter-Defibrillator: temporal trends and clinical implications of the anesthetic strategies adopted at implant
Background and Aims: Subcutaneous implantable cardioverter defibrillator (S-ICD) therapy is well-established therapy for the prevention of sudden cardiac death. Although general anesthesia (GA) was initially advocated for implantation, non-GA has emerged as a feasible alternative in clinical practice. This study evaluated the early and long-term outcomes associated with anesthetic modality during S-ICD implantation procedures. Methods: The HONEST study nationwide, single-arm, observational cohort included all patients implanted with an S-ICD (EMBLEM™, Boston Scientific) in France between 2012 and 2019. GA was characterized by controlled unconsciousness with airway management, while non-GA included all alternative techniques. Results: Among 4,924 patients, 1,041 (21.1%) underwent non-GA. The proportion of non-GA use increased from 2.5% to 26.9% between 2012 and 2019 (p<0.001). Patients implanted with non-GA modality tended to be older (51 ± 14 vs. 50 ± 15 years), had lower left ventricular ejection fraction (41±16 vs. 43±17%), and fewer secondary prevention indications (33 vs. 38%) (all p0.1). Conclusion: Anesthesia strategy used for S-ICD implantation was not associated with poorer short- or long-term clinical outcomes, supporting non–general anesthesia as a feasible alternative in appropriately selected patients.
- 12 June 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (7)
Open AccessEarly complications and long-term outcome of patients treated with a Subcutaneous Cardioverter-Defibrillator: temporal trends and clinical implications of the anesthetic strategies adopted at implant
Background and Aims: Subcutaneous implantable cardioverter defibrillator (S-ICD) therapy is well-established therapy for the prevention of sudden cardiac death. Although general anesthesia (GA) was initially advocated for implantation, non-GA has emerged as a feasible alternative in clinical practice. This study evaluated the early and long-term outcomes associated with anesthetic modality during S-ICD implantation procedures. Methods: The HONEST study nationwide, single-arm, observational cohort included all patients implanted with an S-ICD (EMBLEM™, Boston Scientific) in France between 2012 and 2019. GA was characterized by controlled unconsciousness with airway management, while non-GA included all alternative techniques. Results: Among 4,924 patients, 1,041 (21.1%) underwent non-GA. The proportion of non-GA use increased from 2.5% to 26.9% between 2012 and 2019 (p<0.001). Patients implanted with non-GA modality tended to be older (51 ± 14 vs. 50 ± 15 years), had lower left ventricular ejection fraction (41±16 vs. 43±17%), and fewer secondary prevention indications (33 vs. 38%) (all p0.1). Conclusion: Anesthesia strategy used for S-ICD implantation was not associated with poorer short- or long-term clinical outcomes, supporting non–general anesthesia as a feasible alternative in appropriately selected patients.
- Open Access
- 6 May 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3) , e70359
Left Bundle Branch Area Pacing vs. Biventricular Pacing for Cardiac Resynchronization: Propensity Score Analysis
Background: Left bundle branch area pacing (LBBAP) has emerged as a promising alternative to conventional biventricular pacing (BIVP) for cardiac resynchronization therapy (CRT). While previous data suggest LBBAP may provide superior outcomes, existing evidence needs more data. Methods: This retrospective study included all patients who underwent de‐novo CRT at two centers in France (2022–2024). Procedural and clinical outcomes were compared between LBBAP and BIVP groups for de‐novo CRT indications, using inverse probability weighting propensity score. Results: A total of 314 patients were included (75 LBBAP, 239 BIVP). Patients receiving LBBAP were older and more likely to have atrial fibrillation. Compared to BIVP, LBBAP was associated with shorter procedure time (96 vs. 128 min; p < 0.001), narrower paced QRS (128 vs. 139 ms; p < 0.001), and lower post‐discharge device‐related complications (1% vs. 11%; HR 0.10, 95% CI 0.01–0.84; p = 0.033). At 1‐year, improvement in left ventricular ejection fraction (LVEF) was similar between groups (median ΔLVEF +15%; p = 0.438), as were hyper‐response rates (52% vs. 60%; p = 0.231). After IPW‐PS, no significant differences were observed in heart failure hospitalization (HR 0.99, 95% CI 0.40–2.64; p = 0.999), new‐onset atrial fibrillation (HR 1.69, 95% CI 0.41–6.94; p = 0.492), sustained ventricular arrhythmias (HR 1.23, 95% CI 0.15–6.49; p = 0.828), overall (HR 1.10, 95% CI 0.44–2.62; p = 0.801), and cardiovascular deaths (HR 0.92, 95% CI 0.27–2.79; p = 0.927). Conclusion: LBBAP is associated with comparable resynchronization and clinical outcomes to BIVP, with fewer late complications.
- 6 May 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3) , e70359
Open AccessLeft Bundle Branch Area Pacing vs. Biventricular Pacing for Cardiac Resynchronization: Propensity Score Analysis
Background: Left bundle branch area pacing (LBBAP) has emerged as a promising alternative to conventional biventricular pacing (BIVP) for cardiac resynchronization therapy (CRT). While previous data suggest LBBAP may provide superior outcomes, existing evidence needs more data. Methods: This retrospective study included all patients who underwent de‐novo CRT at two centers in France (2022–2024). Procedural and clinical outcomes were compared between LBBAP and BIVP groups for de‐novo CRT indications, using inverse probability weighting propensity score. Results: A total of 314 patients were included (75 LBBAP, 239 BIVP). Patients receiving LBBAP were older and more likely to have atrial fibrillation. Compared to BIVP, LBBAP was associated with shorter procedure time (96 vs. 128 min; p < 0.001), narrower paced QRS (128 vs. 139 ms; p < 0.001), and lower post‐discharge device‐related complications (1% vs. 11%; HR 0.10, 95% CI 0.01–0.84; p = 0.033). At 1‐year, improvement in left ventricular ejection fraction (LVEF) was similar between groups (median ΔLVEF +15%; p = 0.438), as were hyper‐response rates (52% vs. 60%; p = 0.231). After IPW‐PS, no significant differences were observed in heart failure hospitalization (HR 0.99, 95% CI 0.40–2.64; p = 0.999), new‐onset atrial fibrillation (HR 1.69, 95% CI 0.41–6.94; p = 0.492), sustained ventricular arrhythmias (HR 1.23, 95% CI 0.15–6.49; p = 0.828), overall (HR 1.10, 95% CI 0.44–2.62; p = 0.801), and cardiovascular deaths (HR 0.92, 95% CI 0.27–2.79; p = 0.927). Conclusion: LBBAP is associated with comparable resynchronization and clinical outcomes to BIVP, with fewer late complications.
- Open Access
- 25 March 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (3) , 102604
The HONEST Cohort Study
- 25 March 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (3) , 102604
Open AccessThe HONEST Cohort Study
- Open Access
- 9 March 2026
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (6) , 629-633
Apparent premature battery depletion in a third-generation subcutaneous implantable cardioverter-defibrillator caused by charge count–based longevity estimation failure: A previously unreported mechanism
- 9 March 2026
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (6) , 629-633
Open AccessApparent premature battery depletion in a third-generation subcutaneous implantable cardioverter-defibrillator caused by charge count–based longevity estimation failure: A previously unreported mechanism
- Open Access
- 27 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (6) , ytaf264
U wave mimicking long QT interval: the role of lead selection, repeated electrocardiograms, and premature atrial complexes
- 27 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (6) , ytaf264
Open AccessU wave mimicking long QT interval: the role of lead selection, repeated electrocardiograms, and premature atrial complexes
- 24 April 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (9) , 2049-2060
S-ICD Implantation Following TV-ICD
- 24 April 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (9) , 2049-2060
S-ICD Implantation Following TV-ICD
- 23 January 2025
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 118 (3) , 178-184
Temporal trends in population characteristics and type of device among primary prevention implantable cardioverter defibrillator recipients: The DAI-PP programme
- 23 January 2025
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 118 (3) , 178-184
Temporal trends in population characteristics and type of device among primary prevention implantable cardioverter defibrillator recipients: The DAI-PP programme